Abstract Influenza infection is associated with high hospitalization rates among young children. Rapid diagnosis of influenza infection is particularly useful in order to prevent nosocomial infection and allows for the timely initiation of antiviral treatment. We evaluated the performance
Introduction
Seasonal influenza infection serves as a major cause of morbidity and mortality, particularly among high-risk population groups. It has been associated with marked social and economic consequences, including high rates of academic and occupational absenteeism, as well as significant treatment and hospitalization costs. Influenza infection is associated with elevated hospitalization rates among young children, comparable to those observed among older adults or other high-risk groups [1] [2] [3] . Influenza is also associated with an enhanced morbidity burden within both the outpatient and community settings [4] .
The diagnosis of influenza is usually based on patient history, clinical signs and symptoms, and on the knowledge of local epidemiological status. The combination of fever and cough was reported to increase the likelihood that respiratory disease was influenza, especially in adults [5, 6] . However, the clinical signs and symptoms of influenza infection among children frequently overlap with those caused by other viral infections present among the community [7] . Rapid diagnosis for influenza is useful in order to minimize nosocomial infections, thus, allowing the timely institution of infection control measures [8] . It also allows for the timely administration of antiviral treatment, which is most effective if initiated within 48 h since the onset of symptoms [9] [10] [11] . Finally, tests that yield results rapidly can influence clinical management regarding antibiotic treatment decisions. As a result, the availability and utilization of influenza rapid diagnostic tests within both the laboratory and clinical settings have substantially increased during recent years. The influenza rapid diagnostic tests, providing results within 15 min, have also been applied as screening tests for influenza infection. More than ten types of rapid influenza diagnos-tic tests have been approved by the U.S. Food and Drug Administration (FDA).
The purpose of this study is to evaluate the performance of a rapid influenza test performed at the bedside of hospitalized children during one year's influenza season with the use of reverse transcription polymerase chain reaction (RT-PCR) as the standard diagnostic method. The performance of the rapid test was also compared to the clinical diagnosis of influenza in hospitalized children.
Materials and methods
A cross-sectional study design was conducted during the 2005 respiratory infection season in Athens, Greece. The study period was initiated on January 15, 2005, following the detection of two consecutive pediatric patients with confirmed influenza virus infection, and was concluded on May 15, 2005 , following the conclusion of the influenza season within the region. The study was approved by the Ethical Committee of the P&A Kyriakou Children's Hospital in Athens, Greece. Informed consent for study participation was required from the legal guardians of all eligible participants prior to study participation.
All children, aged 6 months to 14 years, who presented with fever (≥37.8°C, axillary) and/or respiratory symptoms and were consequently hospitalized at the P&A Kyriakou Children's Hospital during the period January 15, 2005 through May 15, 2005, were eligible (N=311). No exclusion criteria, regarding demographic and/or socio-economic characteristics, for study participation were applied.
All study participants were assessed within 48 h following hospital admission. A standardized questionnaire was completed by a study physician for all study participants. The questionnaire was applied in order to obtain detailed information about patients' demographics, previous medical history, the presence and duration of clinical symptoms and signs, physical findings, and laboratory and radiological results. Information about the vaccination status against influenza was also obtained by the vaccine records of the participants.
A nasopharyngeal aspirate (NPA) of 2 ml was obtained from each participant by a pediatrician through the application of a small flexible tube attached to a sterile mucus trap. If such secretions could not be obtained, 2 ml of sterile saline was introduced and re-aspirated. All collected specimens were stored at −70°C until multiplex RT-PCR tests were performed, within one month. A nasal swab of the turbinates was also obtained and tested immediately after collection for the presence of the influenza antigen, by the same researcher, through the application of the QuickVue Influenza Test.
Influenza virological diagnosis
The QuickVue Influenza Test (Quidel, San Diego, CA, USA) was used for the rapid diagnosis of influenza infection. This test is based on a lateral-flow immunoassay and detects the presence of both influenza virus A and influenza virus B, but does not differentiate between the two. The test was performed according to the manufacturer's instructions. The researcher was trained in how to perform the test and read the result. Specifically, the patient's specimen was placed in an extraction tube where the virus particles in the specimen were disrupted, thus, exposing internal virus nucleoprotein. Following extraction, a test strip was placed within the tube, where nucleoproteins in the specimen reacted with both the lyophilized buffer and mouse monoclonal anti-influenza virus A and anti-influenza virus B antibodies contained in the test strip. A positive test result was obtained if a pink or red test line, along with the blue control line, appeared on the test strip, indicating that the extracted specimen contained influenza viral antigens. A negative test result was obtained if only a blue control line appeared, showing that no influenza viruses A or B antigens were present.
Reverse transcription of RNA material isolated from nasopharyngeal samples was performed as described previously [12] . RNA was extracted from 50 μl of nasal aspirates using Trizol reagent (Invitrogen, Carlsbad, CA, USA). Reverse transcription (cDNA synthesis) was performed in 20-μl reactions using 8 μl RNA, Superscript III reverse transcriptase (Invitrogen), and random hexamers.
Multiplex, nested (two rounds) PCRs for influenza virus (serotypes A/H1N1, A/H3N2, B) were conducted in 50-μl reactions consisting of 1× buffer, 3 mM Mg 2+ , 0.2 mM dNTPs, 2U of Platinum Taq DNA polymerase (Invitrogen), and 0.2 μM of each of previously published primers [13] . Four microliters of cDNA were used in the first-round PCR reaction mix, while 2 μl of the PCR product of the first round were used in the amplification mixture of the second round [14] . Samples were amplified in a PTC-200 DNA Engine thermocycler (MJ Research, Waltham, MA, USA) with previously described thermocycling conditions [12] .
Statistical analyses
The primary outcome of the study was assessed by comparing the performance of the QuickVue Influenza Test with that of the multiplex RT-PCR, the currently established criterion standard. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the QuickVue Influenza Test were evaluated both among the overall study population and according to the clinical symptoms of influenza. The sensitivity measures the proportion of actual positives which are correctly identified as such and the specificity measures the proportion of negatives which are correctly identified. However, in practice, the PPV (the proportion of patients with confirmed influenza among patients with a positive rapid test) and the NPV (the proportion of patients without influenza among patients who had negative rapid test) provide the most useful clinical information. Two other tools for the clinician which can help him or her to translate the test characteristics into clinically relevant terms are the positive and negative likelihood ratios (LRP and LRN, respectively). The LRP (= sensitivity/(1 − specificity)) and the LRN ((1 − sensitivity)/specificity) are measures of the discriminating power of a test. LRPs of >10 and LRNs of <0.1 generate large changes from pre-test probability to post-test probability. The translation of pre-test probabilities to post-test probabilities given the likelihood ratio is done with the use of Fagan's normograph [15] . The Chi-square analysis was applied in order to compare patients' characteristics. A P-value ≤0.05 was considered as the criterion for statistical significance for all analyses. Stata version 8 (Stata Corporation, College Station, TX, USA) was used for all analyses.
Results
Among the eligible study population (N=311), 217 (69.8%) were tested by both PCR and the QuickVue Influenza Test for the presence of influenza infection. The 94 (30.2%) eligible study participants were excluded from the study due to either denied informed consent for study participation or limited hospital stay duration (less than 48 h).
Children who participated in the study were almost equally males (108/217) and females (109/217). Fifty-two percent of the participants were between the ages of 12 months and 5 years (Table 1) . One hundred and forty-five children out of 217 (67%) were Greeks, while 47 (22%) were Albanian and 25 (11%) were of other ethnicities. Fourteen study children (7%) were born at gestational age less than 37 weeks. Of the study population, 54 (26%) had predisposing conditions for influenza infection, including asthma (20%), seizures (4%), and congenital heart disease (2%).
Among the study population, 176 (86%) presented with fever (mean temperature 38.9±0.9°C) and 29 children (14%) with respiratory symptoms only. The subgroup of febrile children consisted of 149 patients (85%) with respiratory symptoms; 9 (5%) had vomiting and/or diarrhea, 2 (1%) had abdominal pain, 1 (0.6%) had myalgias, and 6 (3.5%) seizures. The remaining 9 (5%) febrile children were admitted with the diagnosis of a febrile illness without any localizing signs. The main respiratory symptoms were rhinitis (96%) and cough (89%).
According to the PCRs conducted, 18% of the study population had influenza infection, all of which was influenza A (H3N2). The characteristics of patients with and without influenza infection are shown in Table 1 .
The QuickVue Influenza Test detected influenza virus in 27 samples (68%) found to be positive by PCR, but did not detect virus in 13 samples positive by PCR. Seven samples (4%) were positive by the QuickVue Influenza Test but negative by PCR. Based on these findings, the performance of the test was estimated as follows: sensitivity 67.5%, specificity 96%, PPV 79%, and NPV 93% ( Table 2 ). As shown in the table, the LRPs were high, 6.3 to 23, with most being between 12 and 18, and the LRNs varied between 0.08 and 0.5, implying conclusive changes from pre-test probability to post-test probability.
The overall sensitivity of the clinical symptoms of influenza (fever and cough) was 76%, with a PPV of 18%. The specificity and NPV were 20 and 79%, respectively. With regard to the age of the participants, the sensitivity and PPVof clinical symptoms of influenza were higher among children aged between 6 and 12 months as compared with those children aged greater than 12 months (80 and 13% compared to 76 and 19%, respectively). Similar results were found for the specificity and NPV (30 and 92% compared to 18 and 74%, respectively). The positive likelihood ratios and the negative likelihood ratios varied between 0.9 and 1.1, and between 0.7 to 1.4, respectively (Table 3) .
During the 4-week peak period of influenza activity, which accounted for 70% of all instances of influenza virus identification, the sensitivity increased to 76% and the PPV to 86%. The specificity and NPV remained almost the same, 95 and 91%, respectively. The sensitivity and PPV were lower during the first and third phase of the epidemic (sensitivity 57 and 50%, and PPV 67 and 66%, respectively). The specificity changed to 91 and 98%, while the NPV changed to 87 and 96%, respectively ( Table 3) .
The mean duration of symptoms at the time of admission was 4.57±2.43 days. Stratification by reported disease duration showed that the sensitivity and specificity of the QuickVue Influenza Test among hospitalized children with disease duration <2 days were 76 and 100%, respectively. When the QuickVue Influenza Test was performed in children with disease duration longer than 2 days, an estimated sensitivity and specificity of 65 and 94%, respectively, was calculated. The rapid test had higher PPVs with samples from children with shorter disease duration (100 to 71%), but the NPVs were almost the same for both groups (94 to 93%) ( Table 3) .
The sensitivities of the QuickVue Influenza Test were high in samples collected from children aged ≤12 months (80%), but moderate with samples collected from children aged >12 months (66%). The test was highly specific with samples from both age categories (95 to 96%). The PPV was higher with samples from children >12 months (82 vs. 67%), while the NPV was approximately identical (92 to 97%) ( Table 3) .
Discussion
Rapid identification of influenza cases is essential, particularly among hospitalized patients, for the initiation of specific antiviral treatment administration and consequent diminishment of the length of hospitalization. Moreover, the rapid identification of influenza cases may contribute to the limitation of unnecessary antibiotic use and prevention of nosocomial transmission of the virus to high-risk hospitalized population groups [16] [17] [18] .
Previous studies have shown that, during a local outbreak, a clinical presentation including both fever and cough was most indicative of influenza infection among the study population. Specifically, the detection of influenza infection presenting with both fever and cough was observed to have sensitivities ranging between 64 and 86%, specificities between 55 and 67%, and PPVs ranging between 48 and 87% [5, 6, 19, 20] . This contrasts other studies which reported that no clinical signs or symptoms are specific for influenza virus infection [21, 22] . The present study indicates that the clinical diagnosis of influenza, based on the combined presence of fever and cough, is difficult among children in everyday clinical practice. The observed limited PPV indicates that only 18% of the true cases of influenza were identified as such based on patients' symptoms, while the specificity of 20% precludes the use of fever and cough for predicting influenza virus infections. The decreased LRP values and the elevated LRN values make the influenza infection unlikely with the use of clinical symptoms alone. The symptoms were least accurate among children aged less than one year. This finding is in accordance with the clinical experience of diagnosis of respiratory infections among infants, although the burden of influenza is greater in this age group [23, 24] .
In the present study, influenza infection was identified in 18% of children aged 6 months to 14 years who were hospitalized with fever and/or respiratory symptoms. Influenza infections were detected with positive PCR for influenza A and B. PCR was used as the standard criterion because it detects more influenza cases than viral culture and has a greater accuracy [18, 19, 25, 26] . Similarly, our study showed that the QuickVue Influenza Test has a high diagnostic yield for the detection of influenza infection among hospitalized children during the influenza season. The observed performance of the QuickVue Influenza Test is similar to that from previous studies with reported sensitivities and specificities varying between 74 and 93%, and between 76 and 98%, respectively [19, [27] [28] [29] . The observed PPV (79%) indicates that the majority of patients with a positive rapid test truly have influenza infection, while the even greater NPV (93%) indicates that influenza infection is unlikely if the test is negative. Moreover, the LRPs were very high, indicating that a positive result impacts the probability for influenza more than a negative result. For example, if a child has a 50% chance of influenza after history and physical examination, this chance increases to 90-95% (LRP 12-18) with a positive test and decreases to 25-30% (LRN 0.2-0.5) with a negative test. Notice must also be given to the rapid testnegative/PCR-positive subgroup. It is currently unknown whether these patients are truly able to transmit the infection to others due to low viral load that is detected only by the highly sensitive PCR; consequently, it is a matter of further investigation whether these patients should be isolated to prevent transmission to others. Viral shedding is observed to be elevated and more prolonged in children, especially younger patients, compared to adults. Moreover, viral shedding is enhanced during the first days of infection [30, 31] . As a result, infected young children having the test performed during the first days of the disease are more likely to have a positive test as compared to older children with extended disease duration. To this effect, the present study findings indicated that the sensitivity of the rapid test increased to 80% among children aged 6 to 12 months and to 75% among children with symptom onset of less than 2 days.
With regard to the performance of the QuickVue Influenza Test according to the time phase of an influenza epidemic, the study findings indicated that, during the peak of the influenza epidemic, a positive rapid test result is highly indicative (86%) of influenza infection, while a negative test result highly suggests the exclusion of infection (91%). In contrast, during the troughs of the influenza epidemic, the study findings indicated that only half of the positive rapid tests were confirmed influenza cases (PPV 50%). As a result, during such periods, a confirmatory test, such as PCR or viral culture, for detecting influenza cases is necessary. Additionally, it should be noted that, even during periods of low influenza activity, a negative rapid test virtually excludes the diagnosis of influenza (NPV 96%).
Several points, however, must be interpreted with some caution. First, only influenza A was identified in the study samples, so the rapid test characteristics for influenza B infections could not be assessed. Second, the study was conducted in the inpatient setting and the conclusions from the QuickVue Influenza Test cannot be extrapolated to the ambulatory setting, where some differences in disease characteristics may exist, such as viral titers and shorter duration of illness before hospital admission.
Nowadays, under the threat of the ongoing novel influenza A (H1N1) pandemic, it must be added that the use of point-of-care rapid influenza antigen detection tests may also improve the timeliness and appropriateness of decisions regarding the management of hospitalized or ambulatory children. Decisions regarding the initiation of antiviral treatment and application of patient isolation measures may be greatly facilitated if reliable rapid diagnosis is available. Existing rapid antigen detection tests are generally targeted against preserved viral antigens and they have comparable analytical and clinical sensitivity for seasonal influenza A virus and for the new influenza A (H1N1) [32, 33] . Further studies are required to examine the performance characteristics of the antigen detection tests for the diagnosis of influenza caused by this new virus.
In conclusion, our study suggests that the clinical case definition of influenza based on the presence of fever and cough is inaccurate for the prediction of influenza virus infection in children. The QuickVue Influenza Test, on the other hand, is useful and reasonably accurate for the detection of influenza infection in hospitalized children during the influenza season. Infection with influenza virus is less likely if the test is negative. A positive result suggests that infection is probable if influenza virus circulates in the community. On the other hand, in accordance with the World Health Organization (WHO) statement for the use of rapid testing for influenza diagnosis (July 2005), during periods of low influenza activity, if rapid tests are used, positive results must be interpreted Table 3 Comparison of patients' symptoms (fever and cough) with PCR 
